Methods: We used linked health data to identify all non-traumatic lower extremity amputations in adults aged ≥20years with diabetes and/or CVD from 2000 to 2010 in WA. Annual age-and sex-standardised rates of total, initial and recurrent amputations, stratified by major and minor status, were calculated for type 1 and type 2 diabetes, and CVD without diabetes, from the at-risk population for each group. Age-and sex-adjusted trends were estimated from Poisson regression models.
Introduction
Complications of diabetes such as peripheral neuropathy and peripheral vascular disease and their sequelae of foot ulceration, sepsis and lower extremity amputation, are compounded by an ageing population and increasing prevalence of diabetes [1] . In Australia, diabetes-related lower extremity amputations pose a substantial personal and public health cost and contribute disproportionately to diabetes-related inpatient costs [2, 3] .
Although rates of foot ulceration and subsequent wound healing are the best indicators of disease severity and quality of foot care, rates of amputations are easier to measure [4, 5] . Population level trends in initial and recurrent procedures, stratified by diabetes type and by major and minor amputation status, are scarce and have not been reported in Australia. Studies internationally show considerable variation in the incidence of amputations, attributed to methodological factors, healthcare systems, and choices of treatment [5] . Despite these variations, most reports indicate that the incidence of major amputations has fallen over the last two decades [6] [7] [8] [9] .
Assessing trends in amputations in people with and without diabetes is complex and results need to be interpreted carefully. The average incidence and its trend over time may be influenced by type and definition of diabetes, the level of amputation and whether an amputation is an initial (true incident) or recurrent (subsequent) one. It is also crucial that the denominator used for the calculation of amputation rates in people with diabetes is the population at risk, not the whole population [4, 5] .
The aim of this study was to examine trends in lower extremity amputations in Western Australia (WA) using comprehensive state-wide linked data. Trends in initial and recurrent major and 2 minor amputations were compared in patients with type 1 diabetes, type 2 diabetes and cardiovascular disease (CVD) without diabetes between 2000 and 2010.
Materials and Methods
Data for this study were obtained from the Western Australian Data Linkage System (WADLS), which systematically links administrative health data whilst conserving patient privacy [10] . All hospitalisations and death records for an individual are linked by computerised probabilistic matching with manual clerical checking, which has >99% accuracy. The linked dataset included all public and private hospital morbidity and mortality records for all patients admitted with diabetes, CVD or renal disease in WA between 1985 and 2010, and all non-cardiovascular disease records for these patients. Approval for this study was obtained from the Human Patients aged <20 years at the time of amputation were excluded from the study (n=38), as were lower extremity amputations for trauma and cancer. A minor amputation was defined as any amputation distal to the ankle joint (44338-00, 44358-00, 44364-00, 44364-01, 90557-00) and a major amputation as through or proximal to the ankle joint (44361-00, 44361-01, 44367-00, 44367-01, 44367-02). Multiple minor amputations performed during the same admission were counted as a single minor amputation, and a major and minor amputation recorded on the same admission designated as a major amputation only. 3 Amputations were identified as initial if the patient had a 15-year amputation-free history, and all other amputations classified as recurrent. Because the International Classification of Procedures in Medicine and International Classification of Diseases (ICD) version 9 was used in WA prior to July 1999, additional ICD codes were used to determine minor or major amputation status during the look-back period (minor: 5-845, 5-846, 84.11, 84.12; major: 5-847, 5-848, 84.13 -84.17).
Diabetes was identified for each patient from any diagnosis field using 15 years of hospitalisation history prior to amputation (type 1, ICD-9 250.x1, 250.x3/ICD-10 E10; type 2 250.x2, 250.x4/E11). For individuals with inconsistent coding for diabetes type at different hospitalisations, type was assigned based on the most frequent code. Patients were classified as having CVD without diabetes if they had prior hospitalisations for CVD (ICD-9 398-459; ICD-10 I00-I99) but no diabetes coded during the 15-year period prior to their amputation.
Identification of comorbidities was based on hospitalisation history and included coronary heart disease (ICD-10 I20-I25); peripheral vascular disease (I70-I79); chronic kidney disease (CKD, based on the Australian Institute of Health and Welfare definition) [11] ; hypertension (I10-I15); cerebrovascular disease (I60-I69, G45); heart failure (I50); and atrial fibrillation (I48). prevalence, people with prior hospitalisation for CVD but with no diabetes history were identified using the same method. This method has been used previously in linked health data to estimate diabetes prevalence for the calculation of myocardial infarction incidence rates in people with diabetes [12] and for atherothrombotic CVD prevalence [13] . The annual prevalence counts were further adjusted according to prior amputation history for each group.
Statistical Analysis
For example, the denominator for initial amputations in type 1 diabetes was the estimated prevalent type 1 diabetes population with no prior history of amputation. Annual amputation rates were age-and sex-standardised by the direct method using 5-year age groups, with internal weights derived from the person-years of the three groups as the standard population. Age-and sex-adjusted trends were estimated using Poisson log-linear regression models and interactions for age and sex checked and included if significant. Trend estimates were calculated from the exponential of the beta-coefficient for calendar year and are reported as annual percentage changes. Significance was set at p<0.05. Statistical analyses were performed using SAS statistical software V9.4 (Cary, NC, USA). 
Results
There were 2095 major and 3796 minor lower extremity amputations performed in 4221 patients with diabetes or CVD without diabetes in WA from 2000-2010 (Table 1 ). The majority (57.7%) of amputations occurred in patients with type 2 diabetes. There was a considerable male preponderance in all groups, particularly in type 1 and type 2 diabetes. Patients with type 1 diabetes were younger at the time of initial (56.7 years) and recurrent (56.9 years) amputation than patients with CVD and no diabetes (70.7 and 71.9 years respectively) and type 2 diabetes (67.9 and 66.9 years respectively). Minor amputations were more common in patients with diabetes, however this difference was less evident for CVD patients without diabetes (minor :
major ratio 1.4 for initial and 1.1 for recurrent amputations). There were high levels of peripheral vascular disease (71%), hypertension (70%) and chronic kidney disease (60%) across the patient cohort however levels of comorbidity were generally lower in CVD patients without diabetes. In all three groups there was a higher level of comorbidity at the time of recurrent versus initial amputation. There was an over-representation of Aboriginal and Torres Strait
Islander people with type 2 diabetes undergoing amputation (12.8%). 
Total amputations
Amputation rates in people with type 1 diabetes decreased from 1028 to 795 per 100,000, although the trend was not statistically significant (-3.2%/year, 95% CI -6.3, 0.0) ( Table 2 , Figure 1A ). Significant downward trends were observed for the type 2 diabetes and CVD without diabetes groups. No difference in trends was detected between the three groups (p =0.16). Trends in total amputations were driven by large reductions in the rates of major amputations ( Figure 1B ): -5.2%/year in type 1 diabetes, -6.2%/year in type 2 diabetes, and -6.9%/year in CVD without diabetes. Rates of minor amputations were generally higher than major amputations in all groups, with small non-significant declines in the rates of minor amputations in each of the three groups ( Figure 1B ). Annual age-and sex-standardised rates are summarised in Supplementary Table 2 .
Initial amputations
The rate of all initial amputations decreased at approximately 3%/year for each group, underpinned by large declines in initial major amputations (Table 2, Figure 2A ). Although numbers were small in type 1 diabetes and the trend not significant (-8.2%/year, 95% CI -16.6, +1.1), rates fell from 266.7 to 43.6 per 100,000. There was a consistent decline in initial major amputations in type 2 diabetes (111.1 to 60.5 per 100 000), corresponding with an annual decrease of -6.6% (95% CI -8.9, -4.2). There were small downward trends in initial minor amputations but these were not significant in any group. 
Recurrent amputations
The rate of all recurrent amputations remained unchanged in type 1 diabetes. Figure 2B ). There was a significant +3.5% (95% CI +1.3%, +5.7%) increase in recurrent minor amputations in people with type 2 diabetes.
Discussion
Lower extremity amputation rates have declined in WA by ~3% annually between 2000 and 2010. Our analysis showed a similar rate of decline in amputations between type 1 and type 2 diabetes, and also in CVD patients without diabetes. The trends across the three groups were primarily driven by reductions in initial amputations, particularly in major procedures. Rates of total minor amputations did not decrease significantly in any of the three groups, and notably, recurrent minor amputation rates were high with a significant increase in people with type 2 diabetes.
Our study shows encouraging downward trends in rates of total amputations in type 1 and type 2 diabetes at a population level. Although most studies combine these two groups, the few examples where they are reported separately show contrasting results [14] [15] [16] . We observed a similar decline in amputations for type 1 and type 2 diabetes although the changes in type 1 diabetes were not significant -presumably due to the smaller numbers. These trends are an 8 important finding at a population level as they imply effective prevention and management approaches across both patient groups.
In Australia, as elsewhere, the prevalence of diabetes has increased and is now estimated at 6.5%
in WA [17] . Our analysis used type 1 and type 2 prevalent diabetes populations as the denominator for calculating rates, allowing the trends to reflect rates of amputations in people with diabetes. A large U.S. study showed that rates of amputations in people with diabetes fell by 50% between 1990 and 2010 when people with diagnosed diabetes were used as the denominator, yet there was no decrease in rates when the U.S. adult population was used as the denominator [18] . This pattern is similar to that demonstrated by Ikonen et al [14] , highlighting the importance of accounting for changes in the underlying prevalence of diabetes in the population.
Our study is the first to clearly distinguish between trends in initial and recurrent amputations at a population level. This has important implications for patients with and without diabetes, as rates of initial amputations may reflect the effectiveness of primary prevention whereas recurrent amputations reflect treatment and secondary prevention approaches [9] . We have shown that whilst rates of initial, or first-ever, amputations are falling, trends in recurrent amputations appear less favourable. There are likely to be many factors contributing to these differences. A move towards coordinated multidisciplinary care of diabetic foot disease with improved protocols, referral pathways and patient education has evolved in Australia over the last two decades, and this may be a contributing factor in the falling initial amputation rates, particularly in type 2 diabetes. This approach has been shown to reduce amputation rates in other settings, even where absolute numbers of patients presenting with foot ulcers increased [18] . The rate of diagnosis of diabetes itself is increasing due to greater awareness and screening which may result 9 in an increasing proportion of the diabetic population having lesser degrees or durations of hyperglycaemia. Given that the risk of amputation is very low in the first 10 years after diagnosis [19] , this change in the distribution of disease severity could reduce the risk of foot ulceration and initial amputation [7] , however the impact on patients requiring further amputation is as yet unknown.
Our observation that a decreasing incidence of major lower extremity amputations is driving the overall fall in total amputations is consistent with most epidemiological studies from Europe and the US [6, 8, 9, 14, 21] although some studies found no change in major amputation rates [22, 23] .
A study using unlinked national data in Australia reported a decreasing rate of above ankle amputations with concurrent increasing partial foot amputations in the whole population (equivalent to our major and minor classifications respectively) [24] . This pattern is also evident in our person-based linked data analysis of the WA population. However, the former study showed no reduction in total amputations. This contrast with our results is potentially due to inclusion of all recorded procedures, compared with the person-based approach of our study.
The differences between a minor and major amputation for the individual patient and healthcare system are enormous. It is therefore useful to distinguish between the two when assessing rates and trends in amputations. Whilst ulcer prevention or healing remain the main goal of foot care in diabetes, minor amputation has an important role in preventing progression of foot disease in order to avoid the need for a major amputation [25] . This may be most important in patients needing multiple amputations. It is of interest that the only category to show a significant increase in rates was minor recurrent amputations in type 2 diabetes. This increase may reflect changes in surgical practice relying on multiple minor amputations to avoid or at least delay the need for a major amputation [8] . However, it may also reflect the underlying disease burden.
The presence of peripheral vascular disease or peripheral neuropathy in these patients is associated with the onset of diabetic foot ulcers. Poor glycaemic control and the presence of infection are highly predictive of non-healing in this group [26, 27] . Given the high prevalence (>90%) of peripheral vascular disease in the patients with diabetes undergoing recurrent amputations in our study, better management of this and other risk factors associated with diabetic foot ulcers may help to attenuate increasing rates of minor amputations. Other secondary prevention strategies including off-loading and patient education are also priorities in patients with a history of a foot ulcer. Our results highlight the need for better understanding of the factors impacting on trends in minor amputations at a population level. .
Despite the improvements in overall trends, the average rates of amputations in people with diabetes were still up to 10 times higher than the group with CVD and no diabetes in our study. This is despite the fact that our comparator group (CVD and no diabetes) is relatively high-risk, predominated by the presence of peripheral vascular disease, chronic kidney disease and hypertension. Other studies which have used a broader no diabetes comparison group have found lower amputation rates than seen in our CVD group [14, 16] , although have generally reported larger reductions in amputations in people with diabetes than in the non-diabetes group, in contrast to our results. We have previously reported very high recurrence rates for hospitalised peripheral vascular disease in WA [28] , and this finding may be due to the high rate of recurrent amputations as revealed in the current study.
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The strength of this study lies in the quality of data linkage and the ability to use 15 years of hospitalisation records to distinguish between initial and recurrent amputations, major and minor amputations and type 1 and type 2 diabetes in a whole-population setting. This also allowed us to demonstrate trends based on an at-risk population for each amputation type and diabetes status group. Few previous studies have reported trends in this detail. Because of limited wholepopulation diabetes prevalence data, hospital data was used in this study to estimate diabetes prevalence. Hospital-identified diabetes underestimates the true prevalence of diabetes in the population and therefore the rates shown in this study may overestimate actual rates. However trends in amputations in people with diabetes would only be biased if there was a difference in prevalence trends between hospital-based versus whole-population diabetes prevalence. We therefore compared annual hospital-based diabetes prevalence with that from WA self-reported survey data [17] , and found a similar increasing trend of ~2%/year in both data sources for type 1 and type 2 diabetes. This implies that the trends seen in the current study would not be biased by the use of hospitalised diabetes to estimate rates denominators. An important limitation, typical of most administrative datasets, is that side of procedure is not recorded, making it impossible to know whether recurrent amputations were ipsi-or contra-lateral. Whilst the WADLS is regularly audited for data quality [10] , administrative data may be subject to coding misclassification.
However, sensitivity and specificity for the recording of diabetes in hospital morbidity data in WA is high (90% and 95% respectively) in cardiac patients with the use of an extended lookback period [29] , so it is likely that a high level of accuracy was also apparent in our study.
However, we were unable to reliably measure the prevalence of diabetic peripheral neuropathy in our study. Although there is an ICD code for type 2 diabetes with polyneuropathy (E11.42), documentation in medical records and subsequent coding in administrative data is inconsistent. 12 There has been a reassuring decline in population rates of amputations in the high-risk groups of people with type 1 and type 2 diabetes and cardiovascular disease. However, the absolute number of amputations has increased by nearly 50% in patients with type 2 diabetes. This is likely to be due to a combination of increasing prevalence and life expectancy [30] , which has important implications for the planning and funding of services for diabetic foot disease. The high level of vascular comorbidity across patients with diabetes and CVD highlights the need for targeted preventive strategies. Further investigation is needed to identify the factors associated with the increasing rate of recurrent minor amputations in patients with type 2 diabetes and to establish and report appropriate outcomes in this patient group.
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